SightfileU.S. market data from official filings

Companies › HROW

HARROW INC (HROW)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001360214 · EDGAR filings · Updated 2026-06-22

HARROW INC (HROW) has reported institutional ownership of 57.5%, with 217 institutional managers holding positions valued at $755.3M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
57.5%
Institutional managers
217
Reported 13F value
$755.3M
Insider activity
26 trans.
−$10.9M net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, HARROW INC has 217 institutional holders and institutional ownership of 57.5%.

Insider activity

Insiders reported 26 transactions (0 buys, 14 sells) across 4 reporting insiders, with a net reported value of −$10.9M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2025-08-11 (recurring since 2025-03-27) — source filing. The authoritative details are those stated in the filing itself.

Related companies

THERAVANCE BIOPHARMA INC (TBPH) · EVOMMUNE INC (EVMN) · PHATHOM PHARMACEUTICALS INC (PHAT) · ARS PHARMACEUTICALS INC (SPRY) · SCHRODINGER INC (SDGR) · GERON CORP (GERN)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-22.